Bill Commons

CA AB 1794

enacted

Pharmacy: enteral nutrition supplements or replacements.

California · 2025-2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did CA AB 1794 pass?

Yes. CA AB 1794 has been enacted into law. Latest recorded action (2026-09-27): Chaptered by Secretary of State - Chapter 546, Statutes of 2026.

What is CA AB 1794 about?

Existing law, the Pharmacy Law, requires the California State Board of Pharmacy within the Department of Consumer Affairs to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. Under existing law, it is unlawful for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription unless they are licensed, as specified. Existing law authorizes the distribution of drugs and devices directly to dialysis patients pursuant to regulations adopted by the board and other specified conditions. This bill would also authorize a pharmacist, manufacturer, or wholesaler to participate in an arrangement or agreement to deliver enteral nutrition supplements or replacements directly to a patient's residence pursuant to a valid order from a prescriber acting within their scope of practice, and in accordance with the services and activities provided by a pharmacist, consistent with the accepted standard of care, as specified. For these purposes, the bill would define "enteral nutrition supplements or replacements" to mean medical food used as a therapeutic regimen to prevent serious disability or death in patients with medically diagnosed conditions that preclude the full use of regular food. The bill would also make nonsubstantive changes to existing provisions.

Who sponsors CA AB 1794?

Ransom is the primary sponsor of CA AB 1794.

Description

Existing law, the Pharmacy Law, requires the California State Board of Pharmacy within the Department of Consumer Affairs to license and regulate the practice of pharmacy, including pharmacists, pharmacy technicians, and pharmacies. Under existing law, it is unlawful for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription unless they are licensed, as specified. Existing law authorizes the distribution of drugs and devices directly to dialysis patients pursuant to regulations adopted by the board and other specified conditions. This bill would also authorize a pharmacist, manufacturer, or wholesaler to participate in an arrangement or agreement to deliver enteral nutrition supplements or replacements directly to a patient's residence pursuant to a valid order from a prescriber acting within their scope of practice, and in accordance with the services and activities provided by a pharmacist, consistent with the accepted standard of care, as specified. For these purposes, the bill would define "enteral nutrition supplements or replacements" to mean medical food used as a therapeutic regimen to prevent serious disability or death in patients with medically diagnosed conditions that preclude the full use of regular food. The bill would also make nonsubstantive changes to existing provisions.

Introduced
2026-04-14
Latest action
2026-09-27 — Chaptered by Secretary of State - Chapter 546, Statutes of 2026.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Ransomauthor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-09-27

    Chaptered by Secretary of State - Chapter 546, Statutes of 2026.

    became-law

  2. 2026-09-27

    Approved by the Governor.

    executive-signature

  3. 2026-08-31

    Enrolled and presented to the Governor at 4 p.m.

    executive-receipt

  4. 2026-08-25

    Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0.).

    amendment-passage,committee-passage,committee-passage-favorable

  5. 2026-08-25

    Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 6465.).

    amendment-passage,committee-passage,committee-passage-favorable

  6. 2026-08-24

    In Assembly. Concurrence in Senate amendments pending.

  7. 2026-08-24

    Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0.).

    passage,reading-1,reading-3

  8. 2026-06-30

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  9. 2026-06-29

    From committee: Be ordered to second reading pursuant to Senate Rule 28.8.

    committee-passage,reading-1,reading-2

  10. 2026-06-15

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 11. Noes 0.) (June 15). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  11. 2026-06-08

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  12. 2026-05-20

    Referred to Com. on B. P. & E.D.

    referral-committee

  13. 2026-05-12

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  14. 2026-05-11

    Read third time. Passed. Ordered to the Senate. (Ayes 73. Noes 0. Page 4990.)

    passage,reading-1,reading-3

  15. 2026-04-30

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  16. 2026-04-29

    From committee: Do pass. (Ayes 14. Noes 0.) (April 29).

    committee-passage,committee-passage-favorable

  17. 2026-04-16

    Re-referred to Com. on APPR.

    referral-committee

  18. 2026-04-15

    Read second time and amended.

    amendment-passage,reading-1,reading-2

  19. 2026-04-14

    From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 18. Noes 0.) (April 14).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  20. 2026-02-23

    Referred to Com. on B. & P.

    referral-committee

  21. 2026-02-11

    From printer. May be heard in committee March 13.

  22. 2026-02-10

    Read first time. To print.

    reading-1

Versions

  • 02/10/26 - Introduced — 2026-02-10Compare
  • 04/15/26 - Amended Assembly — 2026-04-15Compare
  • 06/08/26 - Amended Senate — 2026-06-08Compare
  • 08/27/26 - Enrolled — 2026-08-27Compare
  • 09/27/26 - Chaptered — 2026-09-27Compare
  • AB1794Compare
  • (document, no version)Compare

Documents

Votes

  • Do pass as amended and be re-referred to the Committee on [Appropriations]

    2026-04-14 · pass · 18-0

    Member-level votes (19)
    • Elhawary: yes
    • Addis: yes
    • Pellerin: yes
    • Macedo: yes
    • Caloza: yes
    • Johnson: yes
    • Irwin: yes
    • Jackson: yes
    • Bauer-Kahan: yes
    • Hart: yes
    • Hadwick: yes
    • Alanis: yes
    • Chen: yes
    • Haney: yes
    • Berman: yes
    • Ahrens: yes
    • Lowenthal: yes
    • Nguyen: yes
    • Bains: other
  • Do pass.

    2026-04-29 · pass · 14-0

    Member-level votes (15)
    • Tangipa: yes
    • Solache: yes
    • Fong: yes
    • Pacheco: yes
    • Hoover: yes
    • Krell: yes
    • Arambula: yes
    • Caloza: yes
    • Mark González: yes
    • Pellerin: yes
    • Wicks: yes
    • Ta: yes
    • Calderon: yes
    • Dixon: yes
    • Muratsuchi: other
  • AB 1794 Ransom Assembly Third Reading

    2026-05-11 · pass · 73-0

    Member-level votes (80)
    • Jackson: yes
    • Lee: yes
    • Boerner: yes
    • Lackey: yes
    • Haney: yes
    • Flora: yes
    • Berman: yes
    • Carrillo: yes
    • Davies: yes
    • Mark González: yes
    • McKinnor: yes
    • Garcia: yes
    • Muratsuchi: yes
    • Rogers: yes
    • Nguyen: yes
    • Ta: yes
    • Hart: yes
    • Johnson: yes
    • Patel: yes
    • Pacheco: yes
    • Ortega: yes
    • Hoover: yes
    • Fong: yes
    • Wicks: yes
    • Chen: yes
    • Ransom: yes
    • Gabriel: yes
    • Blanca Rubio: yes
    • Schiavo: yes
    • Elhawary: yes
    • Connolly: yes
    • Papan: yes
    • Bonta: yes
    • Bains: yes
    • Ávila Farías: yes
    • Gipson: yes
    • Macedo: yes
    • Alvarez: yes
    • Addis: yes
    • Caloza: yes
    • Jeff Gonzalez: yes
    • Stefani: yes
    • Aguiar-Curry: yes
    • Zbur: yes
    • Gallagher: yes
    • Patterson: yes
    • Alanis: yes
    • Pellerin: yes
    • Ellis: yes
    • Ahrens: yes
    • Calderon: yes
    • Dixon: yes
    • Krell: yes
    • Sharp-Collins: yes
    • Bauer-Kahan: yes
    • Bryan: yes
    • Schultz: yes
    • Rivas: yes
    • Valencia: yes
    • Ward: yes
    • Ramos: yes
    • Bennett: yes
    • Tangipa: yes
    • DeMaio: yes
    • Irwin: yes
    • Wilson: yes
    • Hadwick: yes
    • Sanchez: yes
    • Harabedian: yes
    • Wallis: yes
    • Petrie-Norris: yes
    • Castillo: yes
    • Kalra: yes
    • Solache: other
    • Lowenthal: other
    • Michelle Rodriguez: other
    • Soria: other
    • Celeste Rodriguez: other
    • Quirk-Silva: other
    • Arambula: other
  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2026-06-15 · pass · 11-0

    Member-level votes (11)
    • Strickland: yes
    • Choi: yes
    • Menjivar: yes
    • Smallwood-Cuevas: yes
    • Wahab: yes
    • Grayson: yes
    • Umberg: yes
    • Arreguín: yes
    • Niello: yes
    • Archuleta: yes
    • Caballero: yes

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-09-29T23:17:26.091056Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 1794. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.